Sample size in guidelines trials

被引:27
作者
Bland, JM [1 ]
机构
[1] St George Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England
关键词
D O I
10.1093/fampra/17.suppl_1.S17
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In clinical trials, the statistical concepts of significance and power are used in the determination of sample size for trials. The trialist must provide an estimate of standard deviation and a hypothetical population difference to be detected. This must be modified to deal with the designs encountered in guideline research. These are cluster randomized trials, because the patients of a single doctor or practice form a cluster. The trialist must be able to provide information about the effects of clustering, in the form of an intraclass correlation coefficient.
引用
收藏
页码:S17 / S20
页数:4
相关论文
共 12 条
[1]  
Altman DG, 1990, PRACTICAL STAT MED R
[2]  
Armitage P., 2001, STAT METHODS MED RES, V4th
[3]  
Bland JM, 1997, BRIT MED J, V315, P600
[4]  
Bland JM, 1998, BRIT MED J, V316, P129
[5]  
Bland M, 1995, INTRO MED STAT
[6]  
Goldstein H., 2010, Multilevel statistical models, V4th
[7]   Trials which randomize practices I: how should they be analysed? [J].
Kerry, SM ;
Bland, JM .
FAMILY PRACTICE, 1998, 15 (01) :80-83
[8]   Trials which randomize practices II: sample size [J].
Kerry, SM ;
Bland, JM .
FAMILY PRACTICE, 1998, 15 (01) :84-87
[9]   Statistics notes - Analysis of a trial randomised in clusters [J].
Kerry, SM ;
Bland, JM .
BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7124) :54-54
[10]  
Machin D., 1987, STAT TABLES DESIGN C